Its delta symbol for change may prove a harbinger of this tech-centric company.
Startup charts path for Seed, Series A and customer acquisition in healthcare and perhaps beyond.
Startup commercializing VU IP to reduce injury, death and mitigate $50BN annual medical spend.
Entrepreneur who knows both sides of the Law coin weighs-in with ambitious offering.
Newco says it'll pursue capital raise opportunistically among savvy investors.
Artificial Intelligence may rides wave into population health.
[updated] Former Pathfinder exec is CEO in the business that got running start in Centerstone.
IPO, private equity, regardless of the course, there may be a way to preserve the vision.
DRS's passage via the New York City Fintech accelerator was apparently right step.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: